Nasopharyngeal tumors represent 2% of all head and neck cancers in Europe and North America, so that its annual incidence in the U.S. is less than 1 case / 100,000 inhabitants / year. Undoubtedly, their frequency is much higher in South China, North Africa, Greenland and Alaska, where the incidence is 30-50 cases per 100,000 inhabitants / year. The nasopharyngeal carcinoma in Latin America, which is considered a geographical area of little practical effect, is a rare tumor. It is one of the reasons that there are very few studies on this subject in our midst. We conducted a retrospective descriptive study of patients diagnosed with nasopharyngeal carcinoma in the last 10 years in our service. In order to analyze how the different variables present in our midst. The results obtained are similar to those found in the literature. Nasopharyngeal carcinoma is a tumor that affects more males, in terms of age, we found two peaks in an under-30 and another between 50 and 60 years who are diagnosed in advanced stages, in regular consultations is the most frequent, plus cervical lymphadenopathy is a matter of normal consultation with a wide range diagnosis. We only record type carcinoma tumors being the most common tumors in undifferentiated histology.